885963-38-2 Usage
Description
2-Chloro-6-fluoro-benzamidine, with the molecular formula C7H6ClFN2, is a benzanilide derivative belonging to the class of aromatic organic compounds. It is a significant chemical in the field of organic synthesis, characterized by its unique structure and properties.
Uses
Used in Pharmaceutical Industry:
2-Chloro-6-fluoro-benzamidine is used as an intermediate or building block for the production of various pharmaceuticals. Its unique structure allows it to be a key component in the synthesis of drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 2-chloro-6-fluoro-benzamidine is utilized as a precursor in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Organic Chemistry Research:
As a reagent in organic chemistry, 2-chloro-6-fluoro-benzamidine is employed for the synthesis of complex organic molecules. Its versatile chemical properties make it a valuable tool in advancing scientific research and discovery in the field of organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 885963-38-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,9,6 and 3 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 885963-38:
(8*8)+(7*8)+(6*5)+(5*9)+(4*6)+(3*3)+(2*3)+(1*8)=242
242 % 10 = 2
So 885963-38-2 is a valid CAS Registry Number.
885963-38-2Relevant articles and documents
Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1
Wu, Tom Y.H.,Juteau, Hélne,Ducharme, Yves,Friesen, Richard W.,Guiral, Sébastien,Dufresne, Lynn,Poirier, Hugo,Salem, Myriam,Riendeau, Denis,Mancini, Joseph,Brideau, Christine
body text, p. 6978 - 6982 (2011/02/25)
Microsomal prostaglandin E2 synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening identified several leads of mPGES-1 inhibitors which were further optimized for potency and
